Cargando…

Fatty Liver and Insulin Resistance in the Liver-Specific Knockout Mice of Mitogen Inducible Gene-6

Mitogen inducible gene-6 (Mig-6) is a feedback inhibitor of epidermal growth factor receptor (EGFR) signaling pathway. The liver-specific knockout mice of the Mig-6 gene (Mig-6(d/d)) showed hepatomegaly and increased hypercholesterolemia. In this study, the biomarkers of insulin resistance and the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Byung Kil, Lee, Eun-Ah, Kim, Hee-Youn, Lee, Jun Choul, Kim, Koon Soon, Jeong, Won Hoon, Kim, Ki Young, Ku, Bon Jeong, Rhee, Sang Dal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5174183/ https://www.ncbi.nlm.nih.gov/pubmed/28053990 http://dx.doi.org/10.1155/2016/1632061

Ejemplares similares

Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
por: Lee, Jun Choul, et al.
Publicado: (2014)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity
por: Lee, Eaum Seok, et al.
Publicado: (2017)

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
por: Choung, Sorim, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease
por: Kim, Gyuri, et al.
Publicado: (2017)

Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

Effect of physical activity on the development and the resolution of nonalcoholic fatty liver in relation to body mass index
por: Choi, Hyo-In, et al.
Publicado: (2022)

Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
por: Kim, Soon Sun, et al.
Publicado: (2022)

Fatty Liver Is Associated with Low N-Terminal Pro-B-Type Natriuretic Peptide in a Healthy Population
por: Choi, Hyo-In, et al.
Publicado: (2021)

Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease
por: Si, Jiyeon, et al.
Publicado: (2021)

Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study
por: Koo, Dae-Jeong, et al.
Publicado: (2021)

KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure
por: Jang, Ju-hong, et al.
Publicado: (2022)

Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
por: Lim, Tae Seop, et al.
Publicado: (2023)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Fatty liver is an independent risk factor for gallbladder polyps
por: Ahn, Dong-Won, et al.
Publicado: (2020)

Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance
por: Jeong, Seogsong, et al.
Publicado: (2020)

Sex-specific metabolic interactions between liver and adipose tissue in MCD diet-induced non-alcoholic fatty liver disease
por: Lee, Yun-Hee, et al.
Publicado: (2016)

Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease
por: Kim, Min Chul, et al.
Publicado: (2020)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and insulin resistance in children
por: Song, Kyungchul, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease
por: Choe, A Reum, et al.
Publicado: (2020)

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study
por: Lee, Kil Woo, et al.
Publicado: (2015)

Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
por: Lee, Sang Hyub, et al.
Publicado: (2010)

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
por: Song, Yi-Sun, et al.
Publicado: (2013)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease
por: Lee, Jeong In, et al.
Publicado: (2016)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Association between Inflammatory Biomarkers and Nutritional Status in Fatty Liver
por: Lim, Hee-Sook, et al.
Publicado: (2020)

Natural course of fatty liver in 36,195 South Korean adults
por: Sung, Ki-Chul, et al.
Publicado: (2019)

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes
por: Sung, Ki-Chul, et al.
Publicado: (2012)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
por: Lee, Byung-Wan, et al.
Publicado: (2020)

Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease
por: Kim, Sanghwa, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Serum MIG6 concentration is increased by cholesterol-lowering treatment in patients with type 2 diabetes mellitus and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rs3gfoamb7q6p12h0ju7tgnr74